Trium Capital LLP Horizon Therapeutics Public LTD CO Transaction History

Trium Capital LLP

  • $350 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 06, 2023
BUY
$98.98 - $115.74 $12.7 Million - $14.9 Million
128,426 New
128,426 $14.9 Million
Q1 2023

May 16, 2023
BUY
$107.32 - $113.5 $9.21 Million - $9.74 Million
85,776 Added 361.01%
109,536 $12 Million
Q4 2022

Jan 31, 2023
BUY
$62.39 - $113.8 $1.48 Million - $2.7 Million
23,760 New
23,760 $2.7 Million

Others Institutions Holding HZNP

# of Institutions
38
Shares Held
2.07M
Call Options Held
0
Put Options Held
20K
View Full List

About Horizon Therapeutics Public Ltd Co

HZNP Quotes by TradingView
  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Trium Capital LLP Portfolio

Follow Trium Capital LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trium Capital LLP, based on Form 13F filings with the SEC.

News

Stay updated on Trium Capital LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email